solution by MARKET
Pharmaceutical Turnkey Solutions & Equipment for the United States Market
The first Chinese pharmaceutical engineering company to deliver a complete FDA cGMP-compliant IV solution turnkey plant on U.S. soil — with 40+ projects across 20+ countries.
A Clear View of the Local Market Landscape
The U.S. pharmaceutical manufacturing equipment market is valued at over $15.75 billion and projected to reach $22.3 billion by 2035, representing the world’s largest single-country demand. Recent IV fluid supply chain disruptions — including shortages that persisted from 2018 through 2025 — have exposed critical vulnerabilities in domestic production capacity, driving urgent demand for new manufacturing facilities and diversified equipment suppliers. U.S. regulators and healthcare systems are actively incentivizing expanded domestic production of sterile IV solutions, injectables, and essential pharmaceutical products.
Demand Trends Within the Country
-
Domestic IV Production Capacity
Hospitals and health systems need new IV fluid manufacturing plants to reduce reliance on a handful of suppliers and mitigate shortage risks. -
FDA cGMP-Ready Equipment
Buyers require production lines pre-engineered for full FDA cGMP, USP, ISPE, and ASME BPE compliance — ready to pass validation on delivery. -
End-to-End Automation
U.S. manufacturers prioritize highly automated, labor-light production systems that minimize contamination risk and maximize output consistency. -
Speed to Market
With supply chain gaps still present, buyers seek turnkey partners who can compress project timelines from design through commissioning.
Local Experience, Reliable Execution
-
Successfully delivered the first-ever U.S. pharmaceutical turnkey project by a Chinese engineering company — a fully automated IV bag plant built to FDA cGMP, USP43, and GAMP5 standards.
-
40+ completed turnkey projects across 20+ countries, with 2,500+ production lines exported to 60+ nations — proven global-scale execution.
-
Full in-house capability spanning cleanroom engineering, pharmaceutical water systems, filling lines, sterilization, automated inspection, and intelligent packaging — no third-party dependency.
-
60+ proprietary technology patents with dedicated engineering teams available for on-site installation, commissioning, and validation support in the U.S.
Selected Products for This Market
-
Storage Tank
Product Detail Introduction This equipment can be used in medicine, food, chemical industry, liquid material storage. Has a beautiful appearance, easy operation, the tank is equipped with automatic rotating cleaning head, to ensure thorough cleaning, materials used SUS304 or SUS316L, with mirror polished or matte surface treatment, meet the GMP standard. Product Video Parameters Model…
Meeting Local Standards with Reliable Delivery
Compliance & Certification
Logistics & Delivery
Success Snapshot
-
Pharmaceutical Manufacturer
Delivered a complete IV bag soft-infusion turnkey plant — the first such project in the U.S. by a Chinese engineering firm. The facility features full-process automation from water treatment through packaging, validated to FDA cGMP and GAMP5 standards.
-
Leading IV Solution Producer
Built a high-capacity PP bottle IV solution factory producing 72 million bottles annually. The client selected IVEN after evaluating multiple European and Chinese suppliers.
Trusted by Local Customers
-
“IVEN delivered a fully validated, FDA-compliant facility on schedule. Their engineering depth and on-site commitment exceeded our expectations.”
Mr. A
Operations Director
-
“From design through commissioning, the IVEN team demonstrated exceptional technical knowledge of U.S. regulatory requirements. A true turnkey partner.”
Ms. B
VP of Manufacturing
FAQ
Related Market Solutions
Pharmaceutical Production Lines & Turnkey Factory Solutions for Russia
From IV solution filling lines and OSD plants to injectable systems, biologics equipment, and cleanroom engineering — GMP-compliant manufacturing infrastructure built to support Russia’s Pharma 2030 import substitution and full-cycle localization strategy.
